National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021

被引:5
|
作者
Deng, Wenzhen [1 ,2 ]
Zhao, Li [1 ,2 ]
Chen, Cheng [2 ]
Ren, Ziyu [1 ]
Jing, Yuanyuan [1 ]
Qiu, Jingwen [1 ]
Liu, Dongfang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, 74 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Qianjiang Cent Hosp Chongqing, Dept Endocrinol, Qianjiang, Peoples R China
关键词
diabetes mellitus; disability-adjusted life years; global disease burden; incidence; prevalence; INSULIN-RESISTANCE; INTENSITY EXERCISE; BODY-MASS; TYPE-2; EPIDEMIOLOGY; PREVENTION; PREVALENCE; OBESITY; METAANALYSIS; MORTALITY;
D O I
10.1111/1753-0407.70012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIn recent years, the prevalence and mortality rates of diabetes have been rising continuously, posing a significant threat to public health and placing a heavy burden on the population. This study was conducted to describe and analyze the burden of diabetes in China from 1990 to 2021 and its attributable risk factors.MethodsUtilizing data from the Global Burden of Disease Study 2021, we analyzed the incidence, prevalence, and disability-adjusted life years (DALYs) of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) in China from 1990 to 2021. We extracted sex- and age-specific data on diabetes, focusing on DALYs, years lived with disability, and years of life lost. Bayesian meta-regression and spatiotemporal Gaussian process regression were used to estimate disease parameters. Age-standardized rates (ASRs) and estimated annual percentage changes (EAPC) were calculated using direct standardization and log-linear regression. The population-attributable fractions were also determined for each risk factor.ResultsIn 2021, the absolute number of incident diabetes mellitus (DM) cases was estimated at 4003543.82, including 32 000 T1DM and 3971486.24 T2DM cases. The ASRs were 244.57 for DM, 2.67 for T1DM, and 241.9 for T2DM (per 100 000 population). The absolute number of prevalent DM cases was 117288553.93, including 1442775.09 T1DM and 115845778.84 T2DM cases. The ASRs were 6142.29 for DM, 86.78 for T1DM, and 6055.51 for T2DM (per 100 000 population). In 2021, there were 178475.73 deaths caused by DM, with an ASR of mortality of 8.98 per 100 000 population. The DALYs due to DM in 2021 were 11713613.86, with an ASR of 585.43 per 100 000 population and an EAPC of 0.57. This increase can be attributed to several factors, including high body mass index, air pollution, and dietary habits.ConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. imageConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. image HighlightsThe incidence, prevalence, and DALYs rate of diabetes in China are at relatively high levels, with a severe and rapidly growing burden of disability, particularly prominent among males. Interventions should be strengthened for major factors contributing to the diabetes burden, including high fasting plasma glucose, high body mass index, air pollution, and dietary risks. image
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021
    Liang, Jiahui
    Wang, Yue
    Yu, Fei
    Jiang, Guichun
    Zhang, Weiguo
    Tian, Kang
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [2] Global, regional, and national burdens of osteoarthritis from 1990 to 2021: findings from the 2021 global burden of disease study
    Li, Han-Zheng
    Liang, Xue-Zhen
    Sun, Yi-Qing
    Jia, Hai-Feng
    Li, Jia-Cheng
    Li, Gang
    FRONTIERS IN MEDICINE, 2024, 11
  • [3] Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021
    Guo, Jingxun
    Liu, Zhen
    Wang, Pengjun
    Wu, Heming
    Fan, Kai
    Jin, Jianbo
    Zheng, Lan
    Liu, Zeyu
    Xie, Renyi
    Li, Cheng
    FRONTIERS IN MEDICINE, 2025, 11
  • [4] Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021
    Li, Xin-yu
    Kong, Xiang-meng
    Yang, Cheng-hao
    Cheng, Zhi-feng
    Lv, Jia-jie
    Guo, Hong
    Liu, Xiao-hong
    ECLINICALMEDICINE, 2024, 75
  • [5] The global, regional, and national burden of myocarditis in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease Study 2021
    Li, Le
    Ding, Ligang
    Wu, Lingmin
    Hu, Zhicheng
    Liu, Limin
    Zhao, Minghao
    Zhang, Tao
    Zheng, Lihui
    Yao, Yan
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
  • [6] Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study
    Rong, Jian
    Wang, Xueqin
    Cheng, Pan
    Li, Dan
    Zhao, Dahai
    BRITISH JOURNAL OF PSYCHIATRY, 2025,
  • [7] Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021
    Su, Xingyang
    Tao, Yifang
    Chen, Feng
    Han, Xiujuan
    Xue, Li
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] Global burden of viral skin diseases from 1990 to 2021: a systematic analysis for the global burden of disease study 2021
    Li, Deng
    Chen, Ming
    Li, Wei
    Xu, Xuewen
    Li, Qingfeng
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [9] Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021
    Ran, Jun
    Zhou, Ping
    Wang, Jinxi
    Zhao, Xuemei
    Huang, Yan
    Zhou, Qiong
    Zhai, Mei
    Zhang, Yuhui
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [10] The Global, Regional, and National Burden of Pancreatitis From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021
    Zhou, Baichuan
    Zhang, Jingcheng
    Li, Guangxing
    Wei, Yajun
    Xu, Shibo
    Xu, Aman
    Wang, Cheng
    Wang, Gang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025,